Graham K. Cooper
2009 - Orexigen Therapeutics
In 2009, Graham K. Cooper earned a total compensation of $709.8K as Former Chief Financial Officer and Treasurer at Orexigen Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Bonus | $152,000 |
|---|---|
| Option Awards | $65,229 |
| Salary | $288,800 |
| Other | $203,752 |
| Total | $709,781 |
Cooper received $288.8K in salary, accounting for 41% of the total pay in 2009.
Cooper also received $152K in bonus, $65.2K in option awards and $203.8K in other compensation.
Rankings
In 2009, Graham K. Cooper's compensation ranked 5,628th out of 9,885 executives tracked by ExecPay. In other words, Cooper earned more than 43.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,628 out of 9,885 | 43rd |
Division Manufacturing | 2,028 out of 3,690 | 45th |
Major group Chemicals And Allied Products | 424 out of 866 | 51st |
Industry group Drugs | 276 out of 638 | 57th |
Industry Pharmaceutical Preparations | 207 out of 446 | 54th |
Source: SEC filing on April 27, 2012.
Cooper's colleagues
We found seven more compensation records of executives who worked with Graham K. Cooper at Orexigen Therapeutics in 2009.
2009
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2009
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2009
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
2009
Dawn Viveash
Orexigen Therapeutics
Senior Vice President, Regulatory Affairs
2009
Joseph Hagan
Orexigen Therapeutics
Chief Business Officer
2009
Heather Turner
Orexigen Therapeutics
General Counsel
2009
Eckard Weber
Orexigen Therapeutics